Tada T, Kurosaki M, Nakamura S, Hasebe C, et al. Real-world clinical outcomes of sofosbuvir and velpatasvir treatment in HCV genotype 1- and 2-infected patients with decompensated cirrhosis: A nationwide multicenter study by the Japanese Red Cross Liver Study Group. J Med Virol 2021 Jun 25. doi: 10.1002/jmv.27157.
PMID: 34170517